| Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic JP Rogers, E Chesney, D Oliver, TA Pollak, P McGuire, P Fusar-Poli, ... The Lancet Psychiatry 7 (7), 611-627, 2020 | 3112 | 2020 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1631 | 2020 |
| The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings RW Paterson, RL Brown, L Benjamin, R Nortley, S Wiethoff, T Bharucha, ... Brain 143 (10), 3104-3120, 2020 | 1305 | 2020 |
| N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both … SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ... Brain 133 (6), 1655-1667, 2010 | 1210 | 2010 |
| Disease-relevant autoantibodies in first episode schizophrenia MS Zandi, SR Irani, B Lang, P Waters, PB Jones, P McKenna, AJ Coles, ... Journal of neurology 258, 686-688, 2011 | 395 | 2011 |
| Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome S Keddie, J Pakpoor, C Mousele, M Pipis, PM Machado, M Foster, ... Brain 144 (2), 682-693, 2021 | 354 | 2021 |
| Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre RW Paterson, MS Zandi, R Armstrong, A Vincent, JM Schott Journal of Neurology, Neurosurgery & Psychiatry 85 (6), 625-630, 2014 | 152 | 2014 |
| Neurology: a queen square textbook R Howard, D Kullmann, D Werring, M Zandi John Wiley & Sons, 2024 | 125 | 2024 |
| Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes MS Zandi, RW Paterson, MA Ellul, L Jacobson, A Al-Diwani, JL Jones, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (7), 708-713, 2015 | 125 | 2015 |
| Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis J Deakin, BR Lennox, MS Zandi Biological psychiatry 75 (4), 284-291, 2014 | 120 | 2014 |
| Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology JP Rogers, MA Oldham, G Fricchione, G Northoff, J Ellen Wilson, ... Journal of Psychopharmacology 37 (4), 327-369, 2023 | 112 | 2023 |
| Postinfectious brainstem encephalitis associated with SARS-CoV-2 A Khoo, B McLoughlin, S Cheema, RS Weil, C Lambert, H Manji, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (9), 1013-1014, 2020 | 110 | 2020 |
| Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals M Heightman, J Prashar, TE Hillman, M Marks, R Livingston, HA Ridsdale, ... BMJ open respiratory research 8 (1), e001041, 2021 | 98 | 2021 |
| Defining causality in COVID-19 and neurological disorders M Ellul, A Varatharaj, TR Nicholson, TA Pollak, N Thomas, A Easton, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (8), 811-812, 2020 | 91 | 2020 |
| Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma MS Zandi, SR Irani, G Follows, AM Moody, P Molyneux, A Vincent Neurology 73 (23), 2039-2040, 2009 | 90 | 2009 |
| Impaired awareness of motor intention in functional neurological disorder: implications for voluntary and functional movement K Baek, N Doñamayor, LS Morris, D Strelchuk, S Mitchell, Y Mikheenko, ... Psychological Medicine 47 (9), 1624-1636, 2017 | 87 | 2017 |
| Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis JB Badenoch, I Conti, ER Rengasamy, CJ Watson, M Butler, Z Hussain, ... EClinicalMedicine 52, 2022 | 79 | 2022 |
| Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series MS Zandi, JB Deakin, K Morris, C Buckley, L Jacobson, L Scoriels, ... Schizophrenia research 160 (1-3), 193-195, 2014 | 78 | 2014 |
| A novel strategy to reduce the immunogenicity of biological therapies J Somerfield, GA Hill-Cawthorne, A Lin, MS Zandi, C McCarthy, JL Jones, ... The Journal of Immunology 185 (1), 763-768, 2010 | 73 | 2010 |
| Spectrum, risk factors, and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study A Ross Russell, M Hardwick, A Jeyanantham, L White, S Deb, G Burnside, ... | 62 | 2021 |
Thomas A. PollakKing's College LondonBestätigte E-Mail-Adresse bei kcl.ac.uk
